课题基金 / 基金详情

EXPERIMENTAL RADIATION ONCOLOGY CONFERENCE

EXPERIMENTAL RADIATION ONCOLOGY CONFERENCE
实验放射肿瘤学会议
批准号:
3434176
负责人:
MILTON B YATVIN
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1992-07-31

项目摘要

项目成果

MILTON B YATVIN的其他基金

相关文献

中文摘要
翻译
首席研究员在被任命为 俄勒冈州健康科学大学放射肿瘤学系, 第一届“OHSU实验放射肿瘤学会议”于3月16日召开 1989年第17届。 他之前作为两个类似的组织者的经验 1975年和1981年在威斯康星州麦迪逊大学的会议 为第一次波特兰会议的成功作出了巨大贡献。 的 科学界和医学界对这一首次 俄勒冈州会议(所附方案表明波特兰和 西北地区的一个论坛,这将提供一个综合的方法来治疗癌症- 相关话题。 会议的刺激和最近发起的 OHSU校园内的放射生物学项目增加了当地人的兴趣, 对实验性癌症研究的认识。 继续这些“实验性 放射肿瘤学会议"将进一步增加这种兴趣, 意识 出席1989年波特兰会议的不仅仅是当地人。 它 涉及全州范围内的医学和研究社区, 来自国外和欧洲,这提供了一个机会, 来自波特兰(以及西海岸各州)的研究人员交换 与受邀演讲者分享他们的创新工作。 一些 国际公认的工人能够参加波特兰 会议,因为它已被安排为1989年辐射卫星 研究会议。 这样的联系将被保留,以实现利益最大化 同时将应邀发言者的旅费保持在可接受的水平。 第一次会议的经费主要由"Clifford V. 艾伦"基金成立,以荣誉的第一任主席的OHSU辐射 肿瘤科退休。 该基金和其他有限的地方 资源,现在不足以支持进一步的会议。 本 赠款申请确认有必要继续举行这些会议, 在第一次会议成功的基础上再接再厉。 主要目标是 提高俄勒冈州医生和医学科学家对 具有潜在治疗作用的研究领域的发展 影响 每一次会议都将提供一种综合办法, 选择的主题,预计这将证明特别是 引起当地临床医生的兴趣。 会议的形式和相对 少量参与者(60 - 80人)将最大限度地增加机会, 参与者之间的互动讨论。 下一次会议的主题是"内在细胞敏感性和 获得对辐射、热和药物的抵抗力"。 这是临床上 重要性,也是目前大量研究兴趣的焦点, 基础和应用层面。 会议主题 随后的几年是“新的治疗方法的生物学基础”, 分子生物学在癌症治疗中的作用
英文摘要
The Principle Investigator initiated this program on his appointment to the Radiation Oncology Department of Oregon Health Sciences University with the first "OHSU Experimental Radiation Oncology Conference" held on March 16th and 17th 1989. His prior experience as the organizer of two similar meetings at the University of Wisconsin, Madison in 1975 and 1981 contributed greatly to the success of the first Portland Conference. The response by both the scientific and medical communities to this first Oregon meeting (program enclosed demonstrated a need in Portland and the Northwest for a forum which would provide an integrated approach to cancer- related topics. The stimulus of the meeting and the recent initiation of a radiobiology program on the OHSU campus has increased local interest and awareness of experimental cancer studies. Continuing these "Experimental Radiation Oncology Conferences" would further increase this interest and awareness. Attendance at the 1989 Portland meeting was not only local. It involved the medial and research communities state-wide and participants both from out of state and from Europe and this provided an opportunity for researchers from Portland (and the West Coast States generally) to exchange ideas with invited speakers chosen for their innovative work. A number of internationally recognized workers were able to attend the Portland Conference as it had been scheduled as a satellite of the 1989 Radiation Research meeting. Such a link will be retained to maximize the benefits while keeping travel costs for invited speakers to an acceptable level. Funds for the first conference were primarily provided by the "Clifford V. Allen" fund set up to honor the first Chairman of the OHSU Radiation Oncology Department on his retirement. This fund, and other limited local resources, are now insufficient to support a further meeting. The present grant request recognizes the need to continue these conferences and to build on the success of the first meeting. The primary aim will be to stimulate awareness among Oregon physicians and medial scientists of developments in research fields which have potential therapeutic implications. Each Conference will provide an integrated approach to the topic chosen and it is anticipated that this will prove of particular interest to local clinicians. The format of the meeting and the relatively small number of participants (60-80) will maximize opportunities for interactive discussion between the various participants. The topic for the next meeting is "Intrinsic cellular sensitivity and acquired resistance to radiation, heat and drugs". this is of clinical importance and also the focus of substantial current research interest at both the basic and the applied level. The topics for meetings in subsequent years are "Biological bases of novel therapeutic approaches" and "The role of molecular biology in cancer treatments".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USING LIPID LINKED AZT DRUGS TO IMPROVE HIV THERAPY
  • 批准号:
    2422870
  • 项目类别:
  • 资助金额:
    $9.95万
  • 财政年份:
    1997
  • 负责人:
    MILTON B YATVIN
  • 依托单位:
ROLE OF MEMBRANE LIPIDS IN HEAT INJURY
MEMBRANE LIPIDS AND HEAT INJURY
ROLE OF MEMBRANE LIPIDS IN HEAT INJURY